Last updated: 29 April 2024 at 5:10pm EST

Terry-Ann Burrell Net Worth




The estimated Net Worth of Terry Ann Burrell is at least $8.54 Million dollars as of 1 April 2024. Ms. Burrell owns over 5,446 units of Beam Therapeutics stock worth over $1,691,704 and over the last 4 years she sold BEAM stock worth over $2,548,931. In addition, she makes $4,302,720 as Chief Financial Officer and Treasurer at Beam Therapeutics.

Ms. Burrell BEAM stock SEC Form 4 insiders trading

Terry has made over 10 trades of the Beam Therapeutics stock since 2020, according to the Form 4 filled with the SEC. Most recently she sold 5,446 units of BEAM stock worth $174,926 on 1 April 2024.

The largest trade she's ever made was selling 47,195 units of Beam Therapeutics stock on 18 January 2023 worth over $2,130,382. On average, Terry trades about 13,992 units every 81 days since 2020. As of 1 April 2024 she still owns at least 70,137 units of Beam Therapeutics stock.

You can see the complete history of Ms. Burrell stock trades at the bottom of the page.





Terry-Ann Burrell biography

Terry-Ann Burrell serves as Chief Financial Officer, Treasurer of the Company. From May 2008 to August 2019, Ms. Burrell worked at J.P. Morgan Securities LLC, where she most recently served as Managing Director. Ms. Burrell was responsible for deal execution across both mergers and acquisitions and capital markets. In her role, she advised biotechnology and pharmaceutical companies on strategic considerations, including mergers and acquisitions, initial public and secondary offerings and valuation analysis. Ms. Burrell holds a bachelor’s degree from Harvard College and an MBA from New York University’s Leonard N. Stern School of Business.

What is the salary of Terry Burrell?

As the Chief Financial Officer and Treasurer of Beam Therapeutics, the total compensation of Terry Burrell at Beam Therapeutics is $4,302,720. There are no executives at Beam Therapeutics getting paid more.



How old is Terry Burrell?

Terry Burrell is 42, she's been the Chief Financial Officer and Treasurer of Beam Therapeutics since 2019. There are 14 older and 1 younger executives at Beam Therapeutics. The oldest executive at Beam Therapeutics Inc. is Mark Fishman, 68, who is the Independent Director.

What's Terry Burrell's mailing address?

Terry's mailing address filed with the SEC is C/O BEAM THERAPEUTICS INC.,, 238 MAIN STREET, CAMBRIDGE, MA, 02142.

Insiders trading at Beam Therapeutics

Over the last 5 years, insiders at Beam Therapeutics have traded over $63,012,019 worth of Beam Therapeutics stock. The most active insiders traders include Group, Llc Green Jeremy Red..., Llc Fmr, and Kristina Burow. On average, Beam Therapeutics executives and independent directors trade stock every 26 days with the average trade being worth of $1,019,987. The most recent stock trade was executed by Amy Simon on 1 July 2024, trading 1,250 units of BEAM stock currently worth $29,100.



What does Beam Therapeutics do?

Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen receptor T cell for the treatment of relapsed/refractory T-cell acute lymphoblastic leukemia. It also develops therapies for alpha-1 antitrypsin deficiency and glycogen storage disorder 1a; and therapies for ocular and central nervous system disorders. The company has a strategic alliance with Boston Children's Hospital; a research and clinical collaboration agreement with Magenta Therapeutics, Inc.; and a research collaboration with the Institute of Molecular and Clinical Ophthalmology Basel. It also has a research collaboration with Apellis Pharmaceuticals, Inc. to apply base editing technology for discovering new treatments for complement-driven diseases. Beam Therapeutics Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.



What does Beam Therapeutics's logo look like?

Beam Therapeutics Inc. logo

Complete history of Ms. Burrell stock trades at Beam Therapeutics

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
1 Apr 2024 Terry Ann Burrell
Chief Financial Officer
Sale 5,446 $32.12 $174,926
1 Apr 2024
70,137
3 Apr 2023 Terry Ann Burrell
Chief Financial Officer
Sale 4,640 $29.74 $137,994
3 Apr 2023
47,117
26 Jan 2023 Terry Ann Burrell
Chief Financial Officer
Option 37,254 $13.68 $509,635
26 Jan 2023
67,429
23 Jan 2023 Terry Ann Burrell
Chief Financial Officer
Option 20,236 $13.68 $276,828
23 Jan 2023
46,087
18 Jan 2023 Terry Ann Burrell
Chief Financial Officer
Sale 47,195 $45.14 $2,130,382
18 Jan 2023
31,277
31 Mar 2022 Terry Ann Burrell
Chief Financial Officer
Sale 1,787 $59.11 $105,630
31 Mar 2022
38,278
30 Jun 2021 Terry Ann Burrell
Chief Financial Officer
Option 30,000 $13.68 $410,400
30 Jun 2021
54,809
28 Jun 2021 Terry Ann Burrell
Chief Financial Officer
Option 45,000 $13.68 $615,600
28 Jun 2021
69,809
4 Jan 2021 Terry Ann Burrell
Chief Financial Officer
Option 25,000 $13.68 $342,000
4 Jan 2021
32,309
18 Sep 2020 Terry Ann Burrell
Chief Financial Officer
Option 7,309 $13.68 $99,987
18 Sep 2020
7,309


Beam Therapeutics executives and stock owners

Beam Therapeutics executives and other stock owners filed with the SEC include: